Page 7 - Davida Ricks News Today

Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program. Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin. Lilly is cutting the list price of its

As of May 1, non-branded insulins will cost $25 a vial, and Lilly says it will immediately cap out-of-pocket costs at $35 per month.

Plus, a concerning rise in colorectal cancer among young people, what Chicago voters signaled to the rest of the country, and more.

This particular pharmaceutical giant is super proud of itself and wants a cookie. 

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its...

Indy-based Eli Lilly is reducing the price of most of its insulins 70% in an effort to put the drug within reach of more Americans with diabetes.

Some lawmakers have pushed for insulin prices to be capped. Eli Lilly said on Wednesday it will do so voluntarily.

The cap on the diabetes medication by the drugs giant could bring cost relief to many Americans.

Eli Lilly, a U.S. drugmaker is capping the cost of Insulin at $35 per month for seniors with Medicare.

Indy-based Eli Lilly is reducing the price of most of its insulins 70% in an effort to put the drug within reach of more Americans with diabetes.